Enanta Pharma (ENTA) Tops Q4 EPS by 5c

November 21, 2016 4:06 PM EST
Get Alerts ENTA Hot Sheet
Trade ENTA Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $13.23 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment